Dr. Gopal Chemiti, MD

NPI: 1740207745
Total Payments
$956.12
2024 Payments
$216.25
Companies
11
Transactions
15
Medicare Patients
1,005
Medicare Billing
$156,827

Payment Breakdown by Category

Food & Beverage$953.26 (99.7%)
Education$2.86 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $953.26 13 99.7%
Education $2.86 2 0.3%

Top Paying Companies

Company Total Records Latest Year
Bayer Healthcare Pharmaceuticals Inc. $256.73 2 $0 (2023)
Novartis Pharmaceuticals Corporation $132.38 2 $0 (2024)
AstraZeneca Pharmaceuticals LP $125.00 1 $0 (2020)
Mallinckrodt LLC $120.20 1 $0 (2017)
Fresenius USA Marketing, Inc. $108.52 1 $0 (2019)
BAXTER HEALTHCARE $92.17 3 $0 (2019)
Amgen Inc. $83.87 1 $0 (2024)
OPKO Pharmaceuticals, LLC $21.66 1 $0 (2017)
NxStage Medical, Inc. $12.73 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $216.25 3 Novartis Pharmaceuticals Corporation ($132.38)
2023 $145.71 1 Bayer Healthcare Pharmaceuticals Inc. ($145.71)
2022 $111.02 1 Bayer HealthCare Pharmaceuticals Inc. ($111.02)
2021 $1.92 1 Travere Therapeutics, Inc. ($1.92)
2020 $125.00 1 AstraZeneca Pharmaceuticals LP ($125.00)
2019 $153.23 4 Fresenius USA Marketing, Inc. ($108.52)
2017 $202.99 4 Mallinckrodt LLC ($120.20)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/03/2024 Amgen Inc. Food and Beverage In-kind items and services $83.87 General
10/02/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $78.36 General
Category: Immunology
08/28/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $54.02 General
Category: Immunology
09/20/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $145.71 General
Category: Cardio-renal
12/13/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $111.02 General
Category: Cardio-renal
02/25/2021 Travere Therapeutics, Inc. Thiola (Drug) Education In-kind items and services $1.92 General
Category: Kidney Stones
03/05/2020 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
12/13/2019 NxStage Medical, Inc. Food and Beverage In-kind items and services $12.73 General
10/12/2019 Fresenius USA Marketing, Inc. Critline - Monitors (Device) Food and Beverage In-kind items and services $108.52 General
Category: System, Hemodialysis, Access Recirculation Monitoring
10/02/2019 BAXTER HEALTHCARE Renal - PD (Device) Food and Beverage In-kind items and services $16.51 General
Category: Renal
10/02/2019 BAXTER HEALTHCARE Renal - PD (Device) Food and Beverage In-kind items and services $15.47 General
Category: Renal
11/29/2017 Mallinckrodt LLC ACTHAR (Biological) Food and Beverage In-kind items and services $120.20 General
Category: AUTOIMMUNE AND RARE DISEASE
09/19/2017 OPKO Pharmaceuticals, LLC Rayaldee (Drug) Food and Beverage In-kind items and services $21.66 General
Category: Hyperparathyroidism
08/07/2017 BAXTER HEALTHCARE Renal - Non Product Related (Biological) Food and Beverage In-kind items and services $60.19 General
Category: Renal
07/17/2017 Retrophin, Inc. (815) Thiola (Drug) Education In-kind items and services $0.94 General
Category: Kidney Stones

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 279 443 $114,609 $49,980
2022 7 246 443 $91,201 $44,842
2021 8 248 387 $66,038 $33,745
2020 8 232 369 $68,980 $28,260
Total Patients
1,005
Total Services
1,642
Medicare Billing
$156,827
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 17 78 $46,020 $20,702 45.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 133 188 $38,344 $16,204 42.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 50 50 $12,484 $5,096 40.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 28 73 $8,573 $4,387 51.2%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 18 19 $4,226 $1,848 43.7%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 20 22 $3,150 $1,206 38.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 13 $1,812 $535.80 29.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 89 159 $27,921 $14,092 50.5%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 13 47 $23,947 $12,896 53.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 64 64 $17,304 $8,086 46.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 29 114 $13,152 $5,924 45.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 16 17 $3,756 $1,650 43.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 18 21 $2,564 $1,145 44.6%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 17 21 $2,557 $1,049 41.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 95 182 $31,122 $16,300 52.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 50 50 $13,200 $6,117 46.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 30 64 $7,232 $3,626 50.1%
G0426 Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth Facility 2021 15 18 $2,880 $1,928 67.0%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 12 12 $3,816 $1,722 45.1%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 19 25 $2,700 $1,595 59.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 11 19 $3,116 $1,547 49.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 16 17 $1,972 $910.57 46.2%
99204 New patient office or other outpatient visit, typically 45 minutes Office 2020 56 56 $14,784 $7,038 47.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 44 79 $13,509 $6,591 48.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 41 95 $15,212 $5,539 36.4%

About Dr. Gopal Chemiti, MD

Dr. Gopal Chemiti, MD is a Nephrology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740207745.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gopal Chemiti, MD has received a total of $956.12 in payments from pharmaceutical and medical device companies, with $216.25 received in 2024. These payments were reported across 15 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($953.26).

As a Medicare-enrolled provider, Chemiti has provided services to 1,005 Medicare beneficiaries, totaling 1,642 services with total Medicare billing of $156,827. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Salt Lake City, UT
  • Active Since 07/16/2006
  • Last Updated 06/02/2022
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1740207745

Products in Payments

  • Kerendia (Drug) $256.73
  • Fabhalta (Drug) $132.38
  • LOKELMA (Drug) $125.00
  • ACTHAR (Biological) $120.20
  • Critline - Monitors (Device) $108.52
  • Renal - Non Product Related (Biological) $60.19
  • Renal - PD (Device) $31.98
  • Rayaldee (Drug) $21.66
  • Thiola (Drug) $1.92
  • (815) Thiola (Drug) $0.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Salt Lake City